Log In
Print this Print this

Caelyx, Doxil, doxorubicin

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionLiposomal doxorubicin
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today